News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

John Hogwood

Advertisement

John Hogwood is research scientist at NIBSC.

Articles by John Hogwood

Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?

ByAnita Szajek,Elaine Gray,David Keire,Barbara Mulloy,Ali Al-Hakim,Christina Chase,Monica Da Luz Carvalho Soares,Damian Cairatti,John Hogwood,Paulo Mourão,Tina S. Morris, PhD
November 2nd 2015

The global supply chain for bovine and porcine heparin and regulatory considerations are examined.

Advertisement

Latest Updated Articles

  • Diversifying the Global Heparin Supply Chain: Reintroduction of  Bovine Heparin in the United States?
    Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?

    Published: November 2nd 2015 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

AI and Accelerated Computing Propel the Biopharma Ecosystem Forward

2

Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts

3

Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One

4

Sustainability and Stability in Excipients

5

CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us